These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
398 related items for PubMed ID: 19737984
1. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Franzen CA, Amargo E, Todorović V, Desai BV, Huda S, Mirzoeva S, Chiu K, Grzybowski BA, Chew TL, Green KJ, Pelling JC. Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984 [Abstract] [Full Text] [Related]
9. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH. Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621 [Abstract] [Full Text] [Related]
12. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST. Carcinogenesis; 2008 Nov 15; 29(11):2096-105. PubMed ID: 18765415 [Abstract] [Full Text] [Related]
13. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility. Massoner P, Colleselli D, Matscheski A, Pircher H, Geley S, Jansen Dürr P, Klocker H. Endocr Relat Cancer; 2009 Sep 15; 16(3):795-808. PubMed ID: 19509068 [Abstract] [Full Text] [Related]
14. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Slack JK, Adams RB, Rovin JD, Bissonette EA, Stoker CE, Parsons JT. Oncogene; 2001 Mar 08; 20(10):1152-63. PubMed ID: 11313859 [Abstract] [Full Text] [Related]
15. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells. Hui AY, Meens JA, Schick C, Organ SL, Qiao H, Tremblay EA, Schaeffer E, Uniyal S, Chan BM, Elliott BE. J Cell Biochem; 2009 Aug 15; 107(6):1168-81. PubMed ID: 19533669 [Abstract] [Full Text] [Related]
16. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR. Golubovskaya VM, Virnig C, Cance WG. Mol Carcinog; 2008 Mar 15; 47(3):222-34. PubMed ID: 17849451 [Abstract] [Full Text] [Related]
17. The role of the cytoskeleton in differentially regulating pressure-mediated effects on malignant colonocyte focal adhesion signaling and cell adhesion. Thamilselvan V, Basson MD. Carcinogenesis; 2005 Oct 15; 26(10):1687-97. PubMed ID: 15917311 [Abstract] [Full Text] [Related]
18. Troglitazone inhibits cell migration, adhesion, and spreading by modulating cytoskeletal rearrangement in human breast cancer cells. Wang PS, Chou FS, Porchia L, Saji M, Pinzone JJ. Mol Carcinog; 2008 Dec 15; 47(12):905-15. PubMed ID: 18314876 [Abstract] [Full Text] [Related]
19. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling. Coluccia AM, Benati D, Dekhil H, De Filippo A, Lan C, Gambacorti-Passerini C. Cancer Res; 2006 Feb 15; 66(4):2279-86. PubMed ID: 16489032 [Abstract] [Full Text] [Related]
20. Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility. Lacoste J, Aprikian AG, Chevalier S. Mol Cell Endocrinol; 2005 May 12; 235(1-2):51-61. PubMed ID: 15866427 [Abstract] [Full Text] [Related] Page: [Next] [New Search]